Risk factor
Very poor trading liquidity
Profitability factor
Very low or no dividends
About
Pharmigene, Inc. designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally. It offers molecular diagnostics to test adverse drug reactions; and DNA extraction products for gene expression analysis, clinical molecular diagnosis, human identity testing, forensics, and biomedical research applications. The company also provides pharmacogenomics test, drug allergy test, and functional medicine test services. In addition, it distributes various genomics and genetics equipment and reagents; and provides professional consultation, training program, analysis software, and technical support solutions. Further, the company offers CDMO services. The company was founded in 1994 and is headquartered in Taipei, Taiwan.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers.
Buy
Sell